FindTrial
Sign In

Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia

Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00136799
Enrollment
325
Registered
2005-08-29
Start date
2005-06-30
Completion date
2006-04-30
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesterolemia, Mixed Dyslipidemia

Keywords

Mixed Dyslipidemia, high cholesterol, adults, fluvastatin

Brief summary

The purpose of the study is to evaluate the safety and tolerability of fluvastatin 80 mg in a Chinese population. This study is not recruiting patients in the US.

Interventions

DRUGFluvastatin

Sponsors

Novartis
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Mixed dyslipidemia * Primary hypercholesterolemia

Exclusion criteria

* Pregnant or lactating women * Age \> 18 years Other protocol-defined inclusion and

Design outcomes

Primary

MeasureTime frame
Percent change from baseline in low density lipoprotein cholesterol after 12 weeks—

Secondary

MeasureTime frame
Percent change from baseline in total cholesterol after 12 weeks—
Percent change from baseline in high density lipoprotein cholesterol after 12 weeks—
Percent change from baseline in total triglycerides after 12 weeks—

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026